Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Brita A. Winje"'
Autor:
Lamprini Veneti, Bjarne Robberstad, Anneke Steens, Frode Forland, Brita A. Winje, Didrik F. Vestrheim, Christopher I. Jarvis, Amy Gimma, W. John Edmunds, Kevin Van Zandvoort, Birgitte Freiesleben de Blasio
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-18 (2024)
Abstract Background During the COVID-19 pandemic, many countries adopted social distance measures and lockdowns of varying strictness. Social contact patterns are essential in driving the spread of respiratory infections, and country-specific measure
Externí odkaz:
https://doaj.org/article/d59542ba15264a068cf6a8da0bbdbf8d
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
Maternal vaccination against pertussis is safe and provides effective protection against pertussis for the newborn, but the vaccine coverage rate remains generally low. Norway is currently planning for introduction of routine maternal pertussis vacci
Externí odkaz:
https://doaj.org/article/91e6c28e667847cab9ab5fa3a6d673a0
Autor:
Germaine Hanquet, Pavla Krizova, Tina Dalby, Shamez N. Ladhani, J. Pekka Nuorti, Kostas Danis, Jolita Mereckiene, Mirjam J. Knol, Brita A. Winje, Pilar Ciruela, Sara de Miguel, Maria Eugenia Portillo, Laura MacDonald, Eva Morfeldt, Jana Kozakova, Palle Valentiner-Branth, Norman K. Fry, Hanna Rinta-Kokko, Emmanuelle Varon, Mary Corcoran, Arie van der Ende, Didrik F. Vestrheim, Carmen Munoz-Almagro, Juan-Carlos Sanz, Jesus Castilla, Andrew Smith, Birgitta Henriques-Normark, Edoardo Colzani, Lucia Pastore-Celentano, Camelia Savulescu
Publikováno v:
Emerging Infectious Diseases, Vol 28, Iss 1, Pp 137-138 (2022)
We evaluated invasive pneumococcal disease (IPD) during 8 years of infant pneumococcal conjugate vaccine (PCV) programs using 10-valent (PCV10) and 13-valent (PCV13) vaccines in 10 countries in Europe. IPD incidence declined during 2011–2014 but in
Externí odkaz:
https://doaj.org/article/1f129c2eb667436c9c125a71a66c2441
Autor:
Maria Garcia Quesada, Yangyupei Yang, Julia C. Bennett, Kyla Hayford, Scott L. Zeger, Daniel R. Feikin, Meagan E. Peterson, Adam L. Cohen, Samanta C. G. Almeida, Krow Ampofo, Michelle Ang, Naor Bar-Zeev, Michael G. Bruce, Romina Camilli, Grettel Chanto Chacón, Pilar Ciruela, Cheryl Cohen, Mary Corcoran, Ron Dagan, Philippe De Wals, Stefanie Desmet, Idrissa Diawara, Ryan Gierke, Marcela Guevara, Laura L. Hammitt, Markus Hilty, Pak-Leung Ho, Sanjay Jayasinghe, Jackie Kleynhans, Karl G. Kristinsson, Shamez N. Ladhani, Allison McGeer, Jason M. Mwenda, J. Pekka Nuorti, Kazunori Oishi, Leah J. Ricketson, Juan Carlos Sanz, Larisa Savrasova, Lena Petrova Setchanova, Andrew Smith, Palle Valentiner-Branth, Maria Teresa Valenzuela, Mark van der Linden, Nina M. van Sorge, Emmanuelle Varon, Brita A. Winje, Inci Yildirim, Jonathan Zintgraff, Maria Deloria Knoll, the PSERENADE Team
Publikováno v:
Microorganisms, Vol 9, Iss 4, p 738 (2021)
Pneumococcal conjugate vaccine (PCV) introduction has reduced pneumococcal meningitis incidence. The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) project described the serotype distribution of remaining pneumococcal menin
Externí odkaz:
https://doaj.org/article/73aa1284ec7945e3b2909e581f016e3e
Autor:
Julia C. Bennett, Marissa K. Hetrich, Maria Garcia Quesada, Jenna N. Sinkevitch, Maria Deloria Knoll, Daniel R. Feikin, Scott L. Zeger, Eunice W. Kagucia, Adam L. Cohen, Krow Ampofo, Maria-Cristina C. Brandileone, Dana Bruden, Romina Camilli, Jesús Castilla, Guanhao Chan, Heather Cook, Jennifer E. Cornick, Ron Dagan, Tine Dalby, Kostas Danis, Sara de Miguel, Philippe De Wals, Stefanie Desmet, Theano Georgakopoulou, Charlotte Gilkison, Marta Grgic-Vitek, Laura L. Hammitt, Markus Hilty, Pak-Leung Ho, Sanjay Jayasinghe, James D. Kellner, Jackie Kleynhans, Mirjam J. Knol, Jana Kozakova, Karl G. Kristinsson, Shamez N. Ladhani, Laura MacDonald, Grant A. Mackenzie, Lucia Mad’arová, Allison McGeer, Jolita Mereckiene, Eva Morfeldt, Tuya Mungun, Carmen Muñoz-Almagro, J. Pekka Nuorti, Metka Paragi, Tamara Pilishvili, Rodrigo Puentes, Samir K. Saha, Aalisha Sahu Khan, Larisa Savrasova, J. Anthony Scott, Anna Skoczyńska, Shigeru Suga, Mark van der Linden, Jennifer R. Verani, Anne von Gottberg, Brita A. Winje, Inci Yildirim, Khalid Zerouali, Kyla Hayford, the PSERENADE Team
Publikováno v:
Microorganisms, Vol 9, Iss 4, p 696 (2021)
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal disease (IPD) globally before the introduction of pneumococcal conjugate vaccines (PCVs) containing ST1 antigen. The Pneumococcal Serotype Replacement and Distr
Externí odkaz:
https://doaj.org/article/fa3863dfe738434f93946e38c4d0082d
Autor:
Abdi Gele, Prabhjot Kour, Øystein Vedaa, Charlott Nordstrøm, Rebecca Gleditsch, Brita Askeland Winje, Naima Said Sheikh
Publikováno v:
Tidsskrift for Den norske legeforening.
Autor:
Lema Hussaini, Angela S. Labberton, Brita A. Winje, Kristian B. Kraft, Marte Karoline R. Kjøllesdal, Rebecca N. Gleditsch, Anna A. Godøy
Publikováno v:
Vaccine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1782a1656e0982393dfa736e10024ef8
https://hdl.handle.net/11250/3069754
https://hdl.handle.net/11250/3069754
Autor:
Abiot Bezabeh Banti, Sven Gudmund Hinderaker, Brita Askeland Winje, Einar Heldal, Markos Abebe, Mesay Hailu Dangisso, Daniel Gemechu Datiko
ObjectiveIn Ethiopia, a third of the estimated tuberculosis cases are not detected or reported. Incidence estimates are inaccurate and are rarely measured directly. Any tuberculosis program will miss some tuberculosis cases and assessing the ‘‘re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7399dd1c58d2eb2e7f13066c71f69139
https://doi.org/10.1101/2022.11.26.22282775
https://doi.org/10.1101/2022.11.26.22282775
Autor:
Jacob Dag Berild, Brita Askeland Winje, Didrik Frimann Vestrheim, Hans-Christian Slotved, Palle Valentiner-Branth, Adam Roth, Jann Storsäter
Publikováno v:
Pathogens, Vol 9, Iss 4, p 259 (2020)
Adult vaccination is high on the agenda in many countries. Two different vaccines are available for the prevention of pneumococcal disease in adults: a 23-valent polysaccharide vaccine (PPV23), and a 13-valent conjugated vaccine (PCV13). The objectiv
Externí odkaz:
https://doaj.org/article/a95a8342b96b4882b96e82cb5a4d9094
Autor:
Camelia Savulescu, Pavla Krizova, Palle Valentiner-Branth, Shamez Ladhani, Hanna Rinta-Kokko, Corinne Levy, Jolita Mereckiene, Mirjam Knol, Brita A. Winje, Pilar Ciruela, Sara de Miguel, Marcela Guevara, Laura MacDonald, Jana Kozakova, Hans-Christian Slotved, Norman K. Fry, J. Pekka Nuorti, Kostas Danis, Mary Corcoran, Arie van der Ende, Didrik F. Vestrheim, Carmen Munoz-Almagro, Juan-Carlos Sanz, Jesus Castilla, Andrew Smith, Edoardo Colzani, Lucia Pastore Celentano, Germaine Hanquet
Publikováno v:
Vaccine
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Vaccine, 40(29), 3963-3974. Elsevier BV
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
Vaccine, 40(29), 3963-3974. Elsevier BV
Background: Pneumococcal conjugate vaccines covering 10 (PCV10) and 13 (PCV13) serotypes have been introduced in the infant immunization schedule of most European countries in 2010-11. To provide additional real-life data, we measured the effectivene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bf7370d11347f8a97059bcb74e97532
http://hdl.handle.net/10029/626003
http://hdl.handle.net/10029/626003